TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 52 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $30,000 | +66.7% | 38,000 | +111.1% | 0.00% | – |
Q2 2022 | $18,000 | 0.0% | 18,000 | 0.0% | 0.00% | – |
Q1 2022 | $18,000 | 0.0% | 18,000 | 0.0% | 0.00% | – |
Q4 2021 | $18,000 | +20.0% | 18,000 | +20.0% | 0.00% | – |
Q3 2021 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q2 2021 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q1 2021 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q4 2020 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q3 2020 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q2 2020 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q1 2020 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q4 2019 | $15,000 | +7.1% | 15,000 | 0.0% | 0.00% | – |
Q3 2019 | $14,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q2 2019 | $14,000 | -6.7% | 15,000 | 0.0% | 0.00% | – |
Q1 2019 | $15,000 | +7.1% | 15,000 | 0.0% | 0.00% | – |
Q4 2018 | $14,000 | -6.7% | 15,000 | 0.0% | 0.00% | – |
Q3 2018 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q2 2018 | $15,000 | -16.7% | 15,000 | -21.1% | 0.00% | – |
Q1 2018 | $18,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q4 2017 | $18,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q3 2017 | $18,000 | -5.3% | 19,000 | 0.0% | 0.00% | – |
Q2 2017 | $19,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q1 2017 | $19,000 | -5.0% | 19,000 | 0.0% | 0.00% | – |
Q4 2016 | $20,000 | -13.0% | 19,000 | 0.0% | 0.00% | – |
Q3 2016 | $23,000 | -8.0% | 19,000 | 0.0% | 0.00% | – |
Q2 2016 | $25,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q1 2016 | $25,000 | -39.0% | 19,000 | -26.9% | 0.00% | – |
Q4 2015 | $41,000 | +64.0% | 26,000 | +36.8% | 0.00% | – |
Q3 2015 | $25,000 | -7.4% | 19,000 | 0.0% | 0.00% | – |
Q2 2015 | $27,000 | -3.6% | 19,000 | 0.0% | 0.00% | – |
Q1 2015 | $28,000 | +7.7% | 19,000 | 0.0% | 0.00% | – |
Q4 2014 | $26,000 | +8.3% | 19,000 | 0.0% | 0.00% | – |
Q3 2014 | $24,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q2 2014 | $24,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q1 2014 | $24,000 | -36.8% | 19,000 | -47.2% | 0.00% | -100.0% |
Q4 2013 | $38,000 | +90.0% | 36,000 | +89.5% | 0.00% | 0.0% |
Q3 2013 | $20,000 | 0.0% | 19,000 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $20,000 | – | 19,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ZAZOVE ASSOCIATES LLC | 83,413,000 | $130,650,000 | 6.13% |
AEGON USA Investment Management, LLC | 6,000,000 | $9,368,000 | 2.35% |
MACKAY SHIELDS LLC | 24,370,000 | $38,152,000 | 2.07% |
INCOME RESEARCH & MANAGEMENT | 4,374,000 | $6,829,000 | 1.11% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 20,000 | $20,347,000 | 0.99% |
SHENKMAN CAPITAL MANAGEMENT INC | 5,269,000 | $8,264,000 | 0.82% |
Mitsubishi UFJ Securities Holdings Co., Ltd. | 325,000 | $511,000 | 0.76% |
PALISADE CAPITAL MANAGEMENT, LP | 9,299,000 | $14,598,000 | 0.47% |
ADVENT CAPITAL MANAGEMENT /DE/ | 14,543,000 | $23,021,000 | 0.35% |
CSS LLC/IL | 3,750,000 | $5,893,000 | 0.35% |